Literature DB >> 16832098

Autosomal dominant monosymptomatic myotonia permanens.

Eskild Colding-Jørgensen1, Morten Duno, John Vissing.   

Abstract

Myotonia permanens is associated with a G1306E mutation in the SCN4A gene. Two sporadic patients have been reported, but the clinical phenotype has not been fully characterized. The authors report a family in which the disease is autosomal dominantly inherited. The patients have severe myotonia, but the clinical picture is not qualitatively different from that seen in other nondystrophic myotonias.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16832098     DOI: 10.1212/01.wnl.0000223838.88872.da

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

Review 1.  Guidelines on clinical presentation and management of nondystrophic myotonias.

Authors:  Bas C Stunnenberg; Samantha LoRusso; W David Arnold; Richard J Barohn; Stephen C Cannon; Bertrand Fontaine; Robert C Griggs; Michael G Hanna; Emma Matthews; Giovanni Meola; Valeria A Sansone; Jaya R Trivedi; Baziel G M van Engelen; Savine Vicart; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2020-05-27       Impact factor: 3.217

2.  Sodium and chloride channelopathies with myositis: coincidence or connection?

Authors:  Emma Matthews; James A L Miller; Malcolm R MacLeod; James Ironside; Gareth Ambler; Robin Labrum; Richa Sud; Janice L Holton; Michael G Hanna
Journal:  Muscle Nerve       Date:  2011-06-22       Impact factor: 3.217

Review 3.  The nondystrophic myotonias.

Authors:  Chad R Heatwole; Richard T Moxley
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 4.  The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Authors:  E Matthews; D Fialho; S V Tan; S L Venance; S C Cannon; D Sternberg; B Fontaine; A A Amato; R J Barohn; R C Griggs; M G Hanna
Journal:  Brain       Date:  2009-11-16       Impact factor: 13.501

Review 5.  Muscle channelopathies: the nondystrophic myotonias and periodic paralyses.

Authors:  Jeffrey M Statland; Richard J Barohn
Journal:  Continuum (Minneap Minn)       Date:  2013-12

6.  Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.

Authors:  Jean-François Desaphy; Concetta Altamura; Savine Vicart; Bertrand Fontaine
Journal:  J Neuromuscul Dis       Date:  2021

7.  Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy.

Authors:  Jean-François Desaphy; Anna Modoni; Mauro Lomonaco; Diana Conte Camerino
Journal:  Eur J Clin Pharmacol       Date:  2012-10-03       Impact factor: 2.953

8.  Translational approach to address therapy in myotonia permanens due to a new SCN4A mutation.

Authors:  Jean-François Desaphy; Roberta Carbonara; Adele D'Amico; Anna Modoni; Julien Roussel; Paola Imbrici; Serena Pagliarani; Sabrina Lucchiari; Mauro Lo Monaco; Diana Conte Camerino
Journal:  Neurology       Date:  2016-04-29       Impact factor: 9.910

Review 9.  Myotonic disorders: A review article.

Authors:  Chris Hahn; Mohammad Kian Salajegheh
Journal:  Iran J Neurol       Date:  2016-01-05

10.  Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life.

Authors:  Frank Lehmann-Horn; Adele D'Amico; Enrico Bertini; Mauro Lomonaco; Luciano Merlini; Kevin R Nelson; Heike Philippi; Gabriele Siciliano; Frank Spaans; Karin Jurkat-Rott
Journal:  Acta Myol       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.